Organogenesis Holdings (ORGO) Free Cash Flow (QoQ) (2017 - 2026)
Organogenesis Holdings (ORGO) Free Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 322.69 Mn | 230.59 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.28% |
| Dec 31, 2025 | 4,019.43% |
| Sep 30, 2025 | 102.31% |
| Jun 30, 2025 | -54.96% |
| Mar 31, 2025 | -411.00% |
| Dec 31, 2024 | 23.67% |
| Sep 30, 2024 | 330.80% |
| Jun 30, 2024 | 112.99% |
| Mar 31, 2024 | -250.18% |
| Dec 31, 2023 | 400.74% |
| Sep 30, 2023 | -127.70% |
| Jun 30, 2023 | 223.89% |
| Mar 31, 2023 | -147.30% |
| Dec 31, 2022 | 42.29% |
| Sep 30, 2022 | -537.76% |
| Jun 30, 2022 | -69.43% |
| Mar 31, 2022 | -103.60% |
| Dec 31, 2021 | 14.12% |
| Sep 30, 2021 | -15.21% |
| Jun 30, 2021 | 310.12% |